Growth Metrics

Chemours (CC) Accumulated Expenses (2016 - 2025)

Chemours has reported Accumulated Expenses over the past 12 years, most recently at $96.0 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $96.0 million for Q4 2025, down 75.76% from a year ago — trailing twelve months through Dec 2025 was $96.0 million (down 75.76% YoY), and the annual figure for FY2025 was $96.0 million, down 75.76%.
  • Accumulated Expenses for Q4 2025 was $96.0 million at Chemours, down from $580.0 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for CC hit a ceiling of $1.1 billion in Q4 2023 and a floor of $2.0 million in Q2 2021.
  • Median Accumulated Expenses over the past 5 years was $179.5 million (2022), compared with a mean of $298.2 million.
  • Biggest five-year swings in Accumulated Expenses: tumbled 96.0% in 2021 and later skyrocketed 13050.0% in 2022.
  • Chemours' Accumulated Expenses stood at $17.0 million in 2021, then skyrocketed by 1664.71% to $300.0 million in 2022, then skyrocketed by 253.0% to $1.1 billion in 2023, then crashed by 62.61% to $396.0 million in 2024, then crashed by 75.76% to $96.0 million in 2025.
  • The last three reported values for Accumulated Expenses were $96.0 million (Q4 2025), $580.0 million (Q3 2025), and $585.0 million (Q2 2025) per Business Quant data.